Nature Communications (Jan 2018)

IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells

  • Wan-Chen Hsieh,
  • Tzu-Sheng Hsu,
  • Ya-Jen Chang,
  • Ming-Zong Lai

DOI
https://doi.org/10.1038/s41467-018-02862-4
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 15

Abstract

Read online

XLP-2 syndrome is caused by XIAP mutation. Here the authors show that mouse and human XIAP-deficient regulatory T cells have defective suppressive function as a result of conversion to proinflammatory cytokine producing cells, an effect that can be prevented by blocking the IL-6 receptor.